Format

Send to

Choose Destination
JACC Cardiovasc Interv. 2016 Dec 12;9(23):2429-2437. doi: 10.1016/j.jcin.2016.09.019.

Transcatheter Closure of Patent Ductus Arteriosus in Extremely Premature Newborns: Early Results and Midterm Follow-Up.

Author information

1
The Guerin Family Congenital Heart Program, The Heart Institute and Department of Pediatrics, Cedars-Sinai Medical Center, Los Angeles, California. Electronic address: evan.zahn@cshs.org.
2
The Guerin Family Congenital Heart Program, The Heart Institute and Department of Pediatrics, Cedars-Sinai Medical Center, Los Angeles, California.

Abstract

OBJECTIVES:

The goal of this study was to describe early and midterm outcomes of extremely premature newborns (EPNs) who underwent transcatheter echocardiographically guided patent ductus arteriosus (PDA) closure.

BACKGROUND:

Surgical ligation of PDA in EPNs confers significant risk for procedural morbidity and adverse long-term outcomes.

METHODS:

The Amplatzer Vascular Plug II was used in all cases. Post-ligation syndrome was defined using previously published parameters. Patients were followed at pre-specified intervals, and prospectively collected data were reviewed.

RESULTS:

Transcatheter closure was attempted in 24 EPNs (mean procedural age 30 days [range 5 to 80 days], mean procedural weight 1,249 g [range 755 to 2,380 g]) and was successful in 88%. The 3 procedural failures were related to the development of left pulmonary artery (LPA) stenosis caused by the device, and all devices were removed uneventfully. Complications included 2 instances of device malposition, resolved with device repositioning, and 1 instance of LPA stenosis, requiring an LPA stent. There were no procedural deaths, cases of post-ligation syndrome, residual PDA, or device embolization. Survival to discharge was 96% (23 of 24), with a single late death unrelated to the procedure. After a median follow-up period of 11.1 months, all patients were alive and well, with no residual PDA or evidence of LPA or aortic coarctation.

CONCLUSIONS:

This newly described technique can be performed safely with a high success rate and minimal procedural morbidity in EPNs. Early and midterm follow-up is encouraging. Future efforts should be directed toward developing specific devices for this unique application.

KEYWORDS:

device occlusion; patent ductus arteriosus; premature newborn

PMID:
27931595
DOI:
10.1016/j.jcin.2016.09.019
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center